½ÃÀ庸°í¼­
»óǰÄÚµå
1421065

¼¼°èÀÇ °æÄ«Å×ÅÍ ½ÉÀå ÆÇ¸· ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2032³â)

Global Transcatheter Heart Valve Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 131 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 61¾ï 2,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â 237¾ï 9,000¸¸ ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2032³â ¿¬Æò±Õ 16.29%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

°æÄ«Å×ÅÍ ½ÉÀåÆÇ¸·(THV)Àº °æÇÇÀû ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú(TAVR) ¶Ç´Â °æÇÇÀû ´ëµ¿¸ÆÆÇ¸· À̽ļú(TAVI)¿¡ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ´ëµ¿¸ÆÆÇ¸· ÇùÂøÁõ(´ëµ¿¸Æ ÆÇ¸·ÀÌ Á¼¾ÆÁ® ½ÉÀåÀÇ Ç÷·ù°¡ Á¦ÇѵǴ »óÅÂ)À» Ä¡·áÇÏ´Â µ¥ ÀÖ¾î ±âÁ¸ÀÇ °³½É¼úÀ» ´ëüÇÒ ¼ö ÀÖ´Â ÃÖ¼Ò Ä§½ÀÀû Ä¡·á¹ýÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ

°æÄ«Å×ÅÍ ½ÉÀåÆÇ¸·(THV) ½ÃÀåÀº Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ­·Î ÀÎÇÑ ½ÉÀå ÆÇ¸· Áúȯ Áõ°¡ µî ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÃÖ¼Ò Ä§½ÀÀû ½Ã¼úÀÇ ¸Å·ÂÀº Áß¿äÇÑ ¿øµ¿·ÂÀ̸ç, °æÇÇÀû ´ëµ¿¸ÆÆÇ¸· ġȯ¼ú(TAVR)Àº °³½É¼ú¿¡ ´ëÇÑ ¹Ù¶÷Á÷ÇÑ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. ²÷ÀÓ¾ø´Â ±â¼ú ¹ßÀüÀ¸·Î °æÇÇÀû Ä«Å×ÅÍ ½ÉÀå ÆÇ¸·ÀÇ È¿´ÉÀÌ Çâ»óµÇ°í, µðÀÚÀÎ ¹× Àç·áÀÇ °³¼±Àº ´õ ³ªÀº °á°ú¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü Áúȯ Áõ°¡¿Í ÇÔ²² ÀÌ·¯ÇÑ ½Ã¼úÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯¸®ÇÑ »óȯ Á¤Ã¥, ÀÇ·á ±â°ü °£ÀÇ Çù·Â, ÀÇ·á ÀÎÇÁ¶ó °­È­¸¦ À§ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêµµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¼¼°èÀÇ °æÄ«Å×ÅÍ ½ÉÀå ÆÇ¸· ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. °æÄ«Å×ÅÍ ½ÉÀå ÆÇ¸· »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

°æÄ«Å×ÅÍ ½ÉÀå ÆÇ¸· ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼ÇÀº ±¹°¡ ¹× Áö¿ª ¼öÁØÀÇ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡°¡ ÇâÈÄ ±âȸ¸¦ ÅëÇØ °¢ Á¦Ç° ¹× ¼­ºñ½ºÀÇ ´ë»ó °èÃþÀ» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

¿ëµµº°

  • °æÄ«Å×ÅÍ ´ëµ¿¸Æ ¹ëºê
  • °æÄ«Å×ÅÍ Æóµ¿¸Æ ¹ëºê
  • °æÇÇÀû Ä«Å×ÅÍ ½Â¸ðÆÇ¸·

±â¼úº°

  • dz¼± È®Àå °æÇÇ Ä«Å×ÅÍ ¹ëºê
  • ÀÚ°¡ È®ÀåÇü Æ®·£½º Ä«Å×ÅÍ ¹ëºê

Áö¿ªº° ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °æÄ«Å×ÅÍ ½ÉÀå ÆÇ¸· ½ÃÀåÀÇ ÇöÀç¿Í ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

¸ÂÃãÇü ¿ä±¸ »çÇ×ÀÌ ÀÖ´Â °æ¿ì ´ç»ç¿¡ ¹®ÀÇÇϽʽÿÀ. ´ç»çÀÇ Á¶»ç ÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· - »ê¾÷ ºÐ¼®

  • ¼­·Ð - ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • PorterÀÇ Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ¼¼°è ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ¿ëµµº°
  • °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ
  • °æÄ«Å×ÅÍ Æóµ¿¸ÆÆÇ
  • °æÄ«Å×ÅÍ ½Â¸ðÆÇ

Á¦6Àå °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ¼¼°è ½ÃÀå ºÐ¼® : ±â¼úº°

  • °³¿ä : ±â¼úº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ±â¼úº°
  • dz¼± È®ÀåÇü °æÄ«Å×ÅÍ ÆÇ¸·
  • ÀÚ±â È®ÀåÇü °æÄ«Å×ÅÍ ÆÇ¸·

Á¦7Àå °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ±â¾÷ °æÀï ±¸µµ

  • °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀå °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦9Àå ±â¾÷ °³¿ä

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Boston Scientific Corporation
  • Bracco Group
  • Braile Biomedica
  • Direct Flow Medical
  • Edwards Lifesciences
  • JenaValve
  • St. Jude Medical
  • Symetis
  • ValveXchange Inc.
LSH 24.02.16

The global demand for Transcatheter Heart Valve Market is presumed to reach the market size of nearly USD 23.79 BN by 2032 from USD 6.12 BN in 2023 with a CAGR of 16.29% under the study period 2024 - 2032.

Transcatheter heart valve (THV) is a medical device used in transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI). It's a less invasive alternative to traditional open-heart surgery for treating aortic valve stenosis, a condition where the aortic valve becomes narrowed, restricting blood flow from the heart.

MARKET DYNAMICS

The transcatheter heart valve (THV) market is propelled by various factors, including the aging global population, where age-related heart valve diseases are becoming more prevalent. The appeal of less invasive procedures is a significant driver, with Transcatheter Aortic Valve Replacement (TAVR) offering a preferable alternative to open-heart surgery. Continuous technological advancements enhance the efficacy of transcatheter heart valves, with improved designs and materials contributing to better outcomes. Increasing awareness about the benefits of these procedures, coupled with rising cardiovascular disease incidences, fuels the market growth. Favorable reimbursement policies, collaborations between medical entities, and government initiatives aimed at enhancing healthcare infrastructure also play pivotal roles.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of transcatheter heart valve. The growth and trends of transcatheter heart valve industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the transcatheter heart valve market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

  • Transcatheter Aortic Valve
  • Transcatheter Pulmonary Valve
  • Transcatheter Mitral Valve

By Technology

  • Balloon Expanded Transcatheter Valve
  • Self-Expanded Transcatheter Valve

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Transcatheter Heart Valve market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Transcatheter Heart Valve market include Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, St. Jude Medical, Symetis, ValveXchange Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . TRANSCATHETER HEART VALVE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL TRANSCATHETER HEART VALVE MARKET ANALYSIS BY APPLICATION

  • 5.1 Overview by Application
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Application
  • 5.4 Transcatheter Aortic Valve Historic and Forecast Sales by Regions
  • 5.5 Transcatheter Pulmonary Valve Historic and Forecast Sales by Regions
  • 5.6 Transcatheter Mitral Valve Historic and Forecast Sales by Regions

6 . GLOBAL TRANSCATHETER HEART VALVE MARKET ANALYSIS BY TECHNOLOGY

  • 6.1 Overview by Technology
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Technology
  • 6.4 Balloon Expanded Transcatheter Valve Historic and Forecast Sales by Regions
  • 6.5 Self-Expanded Transcatheter Valve Historic and Forecast Sales by Regions

7 . GLOBAL TRANSCATHETER HEART VALVE MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE TRANSCATHETER HEART VALVE COMPANIES

  • 8.1. Transcatheter Heart Valve Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF TRANSCATHETER HEART VALVE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Boston Scientific Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Bracco Group
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Braile Biomedica
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Direct Flow Medical
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Edwards Lifesciences
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. JenaValve
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. St. Jude Medical
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Symetis
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. ValveXchange Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦